These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23579074)

  • 1. Lysine deacetylases and mitochondrial dynamics in neurodegeneration.
    Guedes-Dias P; Oliveira JM
    Biochim Biophys Acta; 2013 Aug; 1832(8):1345-59. PubMed ID: 23579074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G; Jiang H; Chang M; Xie H; Hu L
    J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
    Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
    J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 at the Intersection of Neuroprotection and Neurodegeneration.
    d'Ydewalle C; Bogaert E; Van Den Bosch L
    Traffic; 2012 Jun; 13(6):771-9. PubMed ID: 22372633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
    Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
    Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
    Simões-Pires C; Zwick V; Nurisso A; Schenker E; Carrupt PA; Cuendet M
    Mol Neurodegener; 2013 Jan; 8():7. PubMed ID: 23356410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines.
    Lundh M; Christensen DP; Rasmussen DN; Mascagni P; Dinarello CA; Billestrup N; Grunnet LG; Mandrup-Poulsen T
    Diabetologia; 2010 Dec; 53(12):2569-78. PubMed ID: 20878317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine Deacetylases and Regulated Glycolysis in Macrophages.
    Shakespear MR; Iyer A; Cheng CY; Das Gupta K; Singhal A; Fairlie DP; Sweet MJ
    Trends Immunol; 2018 Jun; 39(6):473-488. PubMed ID: 29567326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
    Wang R; Sun H; Wang G; Ren H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
    Vaquero A; Sternglanz R; Reinberg D
    Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Pandey UB; Nie Z; Batlevi Y; McCray BA; Ritson GP; Nedelsky NB; Schwartz SL; DiProspero NA; Knight MA; Schuldiner O; Padmanabhan R; Hild M; Berry DL; Garza D; Hubbert CC; Yao TP; Baehrecke EH; Taylor JP
    Nature; 2007 Jun; 447(7146):859-63. PubMed ID: 17568747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective.
    Kumar V; Kundu S; Singh A; Singh S
    Curr Neuropharmacol; 2022; 20(1):158-178. PubMed ID: 34151764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.
    Yan J
    DNA Cell Biol; 2014 Sep; 33(9):567-80. PubMed ID: 24932665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 and SIRT2: emerging targets in neurodegeneration.
    Donmez G; Outeiro TF
    EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 1 (SIRT1): the misunderstood HDAC.
    Stünkel W; Campbell RM
    J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Sensitive Lysine Deacetylase Assay Based on Acetylated Firefly Luciferase.
    Spinck M; Ecke M; Sievers S; Neumann H
    Biochemistry; 2018 Jul; 57(26):3552-3555. PubMed ID: 29851343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.
    Richter-Landsberg C; Leyk J
    Acta Neuropathol; 2013 Dec; 126(6):793-807. PubMed ID: 23912309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
    Li P; Ge J; Li H
    Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.